BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17882360)

  • 1. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
    Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of fungemia caused by Blastoschizomyces capitatus].
    Koç AN; Copur Çiçek A; Kaynar L; Sav H; Kasap Tekinşen FF; Atalay MA
    Mikrobiyol Bul; 2013 Oct; 47(4):734-41. PubMed ID: 24237444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
    Ramírez I; Moncada D
    Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
    Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichosporon asahii fungemia in a patient with non-hematological malignancy.
    Karabay O; Madariaga MG; Kocoglu E; Ince N; Kandirali E
    Jpn J Infect Dis; 2006 Apr; 59(2):129-31. PubMed ID: 16632916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
    Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates.
    Kubiça TF; Denardi LB; Azevedo MI; Oliveira V; Severo LC; Santurio JM; Alves SH
    Braz J Infect Dis; 2016; 20(6):539-545. PubMed ID: 27697432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
    Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
    Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
    Dabas Y; Xess I; Kale P
    Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.
    Li H; Qiao J; Wan Z; Zhang J
    Mycopathologia; 2011 May; 171(5):345-8. PubMed ID: 21153882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Antachopoulos C; Papakonstantinou E; Dotis J; Bibashi E; Tamiolaki M; Koliouskas D; Roilides E
    J Pediatr Hematol Oncol; 2005 May; 27(5):283-5. PubMed ID: 15891566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
    Bassetti M; Bisio F; Di Biagio A; Pierri I; Balocco M; Soro O; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2004 Aug; 54(2):575-7. PubMed ID: 15231763
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
    Liao Y; Yang S; Cong L; Lu X; Ao J; Yang R
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7615-6. PubMed ID: 25246408
    [No Abstract]   [Full Text] [Related]  

  • 17. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
    Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
    J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
    Cardenas-de la Garza JA; Ancer-Arellano J; Cuellar-Barboza A; Saenz-Ibarra B; Ocampo-Garza SS; Barboza-Quintana O; Gallardo-Rocha A; Vera-Cabrera L; Ocampo-Candiani J; Welsh O
    J Dermatol; 2019 Apr; 46(4):e128-e129. PubMed ID: 30295013
    [No Abstract]   [Full Text] [Related]  

  • 20. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
    Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J
    Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.